Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir P Tamiz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neuron|March 29, 2022
A focus on the neural exposomeAmir P Tamiz, Walter J Koroshetz, Neel T Dhruv, et al.
Peptides|March 10, 2012
Larazotide acetate promotes tight junction assembly in epithelial cellsShobha Gopalakrishnan, Amit Tripathi, Amir P Tamiz, et al.
Chemical Biology & Drug Design|March 13, 2012
Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesElena V Rosca, Jacob E Koskimaki, Niranjan B Pandey, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2008
Structure-activity relationship studies of permeability modulating peptide AT-1002Min Li, Ed Oliver, Kelly M Kitchens, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2020
Critical NIH Resources to Advance Therapies for Pain: Preclinical Screening Program and Phase II Human Clinical Trial NetworkSmriti Iyengar, Sarah A Woller, Rebecca Hommer, et al.
Current Pharmaceutical Biotechnology|April 8, 2011
Anti-angiogenic peptides for cancer therapeuticsElena V Rosca, Jacob E Koskimaki, Corban G Rivera, et al.
International Journal of Pharmaceutics|October 4, 2008
Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancerShobha Gopalakrishnan, Niranjan Pandey, Amir P Tamiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2019
The Opioid Crisis and the Future of Addiction and Pain TherapeuticsNathan P Coussens, G Sitta Sittampalam, Samantha G Jonson, et al.
Peptides|March 10, 2012
Larazotide acetate regulates epithelial tight junctions in vitro and in vivoShobha Gopalakrishnan, Malarvizhi Durai, Kelly Kitchens, et al.
Expert Opinion on Therapeutic Targets|November 25, 2022
Preclinical target validation for non-addictive therapeutics development for painRichard Hargreaves, Karen Akinsanya, Seena K Ajit, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuron|March 29, 2022
A focus on the neural exposomeAmir P Tamiz, Walter J Koroshetz, Neel T Dhruv, et al.
Peptides|March 10, 2012
Larazotide acetate promotes tight junction assembly in epithelial cellsShobha Gopalakrishnan, Amit Tripathi, Amir P Tamiz, et al.
Chemical Biology & Drug Design|March 13, 2012
Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesElena V Rosca, Jacob E Koskimaki, Niranjan B Pandey, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2008
Structure-activity relationship studies of permeability modulating peptide AT-1002Min Li, Ed Oliver, Kelly M Kitchens, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 3, 2020
Critical NIH Resources to Advance Therapies for Pain: Preclinical Screening Program and Phase II Human Clinical Trial NetworkSmriti Iyengar, Sarah A Woller, Rebecca Hommer, et al.
Current Pharmaceutical Biotechnology|April 8, 2011
Anti-angiogenic peptides for cancer therapeuticsElena V Rosca, Jacob E Koskimaki, Corban G Rivera, et al.
International Journal of Pharmaceutics|October 4, 2008
Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancerShobha Gopalakrishnan, Niranjan Pandey, Amir P Tamiz, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2019
The Opioid Crisis and the Future of Addiction and Pain TherapeuticsNathan P Coussens, G Sitta Sittampalam, Samantha G Jonson, et al.
Peptides|March 10, 2012
Larazotide acetate regulates epithelial tight junctions in vitro and in vivoShobha Gopalakrishnan, Malarvizhi Durai, Kelly Kitchens, et al.
Expert Opinion on Therapeutic Targets|November 25, 2022
Preclinical target validation for non-addictive therapeutics development for painRichard Hargreaves, Karen Akinsanya, Seena K Ajit, et al.
Pageof 1